Acknowledgments

This research was funded by High Plains Nutrition, LLC with a contribution from Friends of Hemp, Inc., a non-profit hemp organization. The author wishes to thank Dr. Volker Bornemann and his team at Avazyme, Inc., for the development of the low-LOQ testing method and the analytical work on the data used in this study. Also, the author thanks Dr. Manisha Das at the FDA-CVM for reviewing the testing protocol and technical procedures used in the analytical testing. Finally, the author wants to thank all those participating in the process, reviewing this paper, and giving their thoughtful feedback.
Table 7: Phase 1 (untrimmed) data with outliers highlighted